| BMJ | Lancet | NEJM | JAMA | ANNALS | Total | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Editorials | 261 | Â | 3504 | Â | 124 | Â | 102 | Â | 39 | Â | 876 | Â |
UK | 160 | 61.4% | 167 | 47.7% | 10 | 8.0% | 02 | 1.9% | 01 | 2.4% | 340 | 38.8% |
USA | 38 | 14.6% | 87 | 24.9% | 97 | 78.3% | 97 | 95.0% | 35 | 90.0% | 354 | 40.4% |
OEAC1 | 56 | 21.4% | 89 | 25.4% | 14 | 11.3% | 02 | 1.9% | 03 | 7.6% | 164 | 18.7% |
RoW2 | 07 | 2.6% | 07 | 2.0 % | 03 | 2.4% | 01 | 0.9% | 00 | 0.0% | 18 | 2.6% |
Original papers | 322 | Â | 307 | Â | 218 | Â | 227 | Â | 115 | Â | 1189 | Â |
UK | 216 | 67.0% | 66 | 21.5 % | 06 | 2.7% | 04 | 1.8% | 03 | 2.6% | 295 | 24.8% |
USA | 22 | 7.0% | 38 | 12.4% | 107 | 49.1% | 173 | 76.2% | 81 | 70.4% | 421 | 35.4% |
OEAC | 76 | 23.6% | 136 | 44.3 % | 78 | 35.8% | 42 | 18.5% | 23 | 20.0% | 355 | 29.9% |
RoW | 08 | 2.4% | 67 | 21.8% | 27 | 12.4% | 08 | 3.5% | 08 | 7.0% | 118 | 9.9% |
Correspondence | 1118 | Â | 10435 | Â | 894 | Â | 605 | Â | 251 | Â | 3911 | Â |
UK | 829 | 74% | 374 | 35.8% | 30 | 3.4% | 13 | 2.1% | 04 | 1.6% | 1250 | 32% |
USA | 69 | 6% | 141 | 13.5% | 601 | 67.2% | 506 | 83.6% | 183 | 72.9% | 1500 | 38.4% |
OEAC | 174 | 16% | 400 | 38.3% | 212 | 23.7% | 71 | 11.7% | 49 | 19.5% | 906 | 23.2% |
RoW | 46 | 4% | 128 | 12.2% | 51 | 5.7% | 15 | 2.5% | 15 | 6.0% | 255 | 6.5% |
Review articles | 286 | Â | 50 | Â | 65 | Â | 36 | Â | 66 | Â | 503 | Â |
UK | 195 | 68.2% | 17 | 34% | 04 | 6.2% | 01 | 2.7% | 01 | 1.6% | 218 | 43.3% |
USA | 29 | 10.2% | 15 | 30% | 48 | 73.8% | 28 | 78.0% | 61 | 92.4% | 181 | 36% |
OEAC | 54 | 18.8% | 14 | 28% | 13 | 20.0% | 04 | 11.1% | 04 | 6.0% | 89 | 17.7% |
RoW | 08 | 2.8% | 04 | 08% | 00 | 0.0% | 03 | 8.2% | 00 | 0.0% | 15 | 3% |
Others3 | 47 | Â | 208 | Â | 149 | Â | 145 | Â | 27 | Â | 576 | Â |
UK | 31 | 66.0% | 68 | 32.8% | 03 | 02.0% | 00 | 00.0% | 00 | 00.0% | 102 | 17.7% |
USA | 08 | 17.0% | 34 | 16.3% | 118 | 79.3% | 120 | 82.7% | 25 | 92.6% | 305 | 53% |
OEAC | 04 | 8.5% | 78 | 37.5% | 22 | 14.7 % | 16 | 11.0% | 01 | 3.7% | 121 | 21% |
RoW | 04 | 8.5% | 28 | 13.4% | 06 | 4.0% | 09 | 6.2% | 01 | 3.7% | 48 | 8.3% |
Global total | 2034 | Â | 1958 | Â | 1450 | Â | 1115 | Â | 498 | Â | 7055 | Â |
RoW total | 73 | 3.6% | 234 | 12% | 87 | 6% | 36 | 3.2% | 24 | 4.8% | 454 | 6.4 % |